In developing fetuses, infection by the Zika virus can result in devastating neurological damage, most notably microcephaly and other brain malformations. In a new study, published today in The Journal of Experimental Medicine, researchers at the University of California San Diego School of Medicine and Washington University School of Medicine in St. Louis report the virus specifically targets and kills brain cancer stem cells.
The findings suggest the lethal power of the virus notorious for causing infected babies to be born with under-sized, misshapen heads could be directed at malignant cells in adult brains. Doing so might potentially improve survival rates for patients diagnosed with glioblastomas, the most common and aggressive form of brain cancer, with a median survival rate of just over 14 months after diagnosis.
The Zika virus specifically targets neuroprogenitor cells in fetal and adult brains. Our research shows it also selectively targets and kills cancer stem cells, which tend to be resistant to standard treatments and a big reason why glioblastomas recur after surgery and result in shorter patient survival rates, said Jeremy Rich, MD, professor of medicine at UC San Diego School of Medicine. Rich is co-senior author of the study with Michael S. Diamond, MD, PhD, professor, and Milan G. Chheda, MD, assistant professor, both at Washington University School of Medicine in St. Louis.
Transmission electron microscope image of negative-stained, Fortaleza-strain Zika virus (red), isolated from a microcephaly case in Brazil. Image courtesy of NIAID.
This year, more than 12,000 Americans will be diagnosed with glioblastomas, according to the American Brain Tumor Association. Among them: U.S. Senator John McCain, who announced his diagnosis in July. They are highly malignant. The two-year survival rate is 30 percent.
Standard treatment is aggressive: surgery, followed by chemotherapy and radiation. Yet most tumors recur within six months, fueled by a small population of glioblastoma stem cells that resist and survive treatment, continuing to divide and produce new tumor cells to replace those killed by cancer drugs.
For Zhe Zhu, MD, PhD, a postdoctoral scholar in Richs lab and first author of the study, the hyper-reproductive capabilities of glioblastoma stem cells reminded him of neuroprogenitor cells, which fuel the explosive growth of developing brains. Zika virus specifically targets and kills neuroprogenitor cells.
So Zhu, with Rich, Diamond, Chheda and other collaborators, investigated whether the Zika virus might also target and kill cultured glioblastoma stem cells derived from patients being treated for the disease. They infected cultured tumors with one of two strains of the virus. Both strains spread through the tumors, infecting and killing stem cells while largely avoiding other tumor cells.
The findings, the authors said, suggest that chemotherapy-radiation treatment and a Zika infection appear to produce complementary results. Standard treatment kills most tumor cells but typically leaves stem cells intact. The Zika virus attacks stem cells but bypasses ordinary tumor cells.
We see Zika one day being used in combination with current therapies to eradicate the whole tumor, said Chheda, an assistant professor of medicine and of neurology at Washington University School of Medicine.
To find out whether the virus could boost treatment efficacy in a live animal, researchers injected either the Zika virus or a saltwater placebo directly into glioblastoma tumors in 18 and 15 mice, respectively. Two weeks after injection, tumors were significantly smaller in the Zika-treated mice, who survived significantly longer than those given the placebo.
The scientists note that the idea of injecting a virus notorious for causing brain damage into patients brains seems alarming, but they say Zika may prove a safe therapy with further testing because its primary target neuroprogenitor cells are rare in adult brains. The opposite is true of fetal brains, which is part of the reason why a Zika infection before birth produces widespread and severe brain damage while a normal Zika infection in adults typically causes mild symptoms or none at all.
The researchers also conducted studies of the virus using brain tissue from epilepsy patients that showed the virus does not infect non-cancerous brain cells.
As an additional safety feature, the research team introduced two mutations that weakened the viruss ability to combat natural cellular defenses against infection, reasoning that while the mutated virus would still be able to grow in tumor cells, which have a poor anti-viral defense system, it would be quickly eliminated in healthy cells with a robust anti-viral response.
When they tested the mutated viral strain and the original parental strain in glioblastoma stem cells, they found that the original strain was more potent, but that the mutant strain also succeeded in killing the cancerous cells.
Were going to introduce additional mutations to sensitize the virus even more to the innate immune response and prevent the infection from spreading, said Diamond, a professor of molecular microbiology, pathology and immunology. Once we add a couple more, I think its going to be impossible for the virus to overcome them and cause disease.
Co-authors of the study include: Matthew Gorman, Estefania Fernandez, Lisa McKenzie, Jiani Chai, Justin M. Richner, and Rong Zhang, Washington University, St. Louis; Christopher Hubert, and Briana Prager, Cleveland Clinic; Chao Shan, and Pei-Yong Shi, University of Texas Medical Branch; and Xiuxing Wang, UC San Diego.
Funding for this research came, in part, from the National Institutes of Health (R01 AI073755, R01 AI104972, CA197718, CA154130, CA169117, CA171652, NS087913, NS089272), the Pardee Foundation, the Concern Foundation, the Cancer Research Foundation and the McDonnell Center for Cellular and Molecular Neurobiology of Washington University.
Go here to see the original:
Zika Virus Targets and Kills Brain Cancer Stem Cells - UC San Diego Health
- Crispr's next frontier is in-human treatment, says co-inventor - The Business Times - October 21st, 2019
- Damien Cook confident that Sam Burgess will continue playing despite shoulder injury - Sporting News AU - October 21st, 2019
- Teen Cancer Survivor uses Haunted House to Help Others Fight - WFMYNews2.com - October 21st, 2019
- Five ways fasting can help in the fight against cancer - The Standard - October 21st, 2019
- Brooks Koepka Withdraws in Korea After Reaggravating Knee Injury - Golf Channel - October 19th, 2019
- Injured Williamson to miss start of season | Sports | Journal Gazette - Fort Wayne Journal Gazette - October 19th, 2019
- New Gene Therapy Approach Reduces Cost and Improves Efficiency - DocWire News - October 19th, 2019
- StemSpine to Launch in the United States Following Successful Treatments Overseas with 12+ Months Data Showing Safety and Efficacy (CELZ) - Stock Day... - October 19th, 2019
- Stem cells treatment gives hope in fighting Autism, blood disorders - OrissaPOST - October 19th, 2019
- The 'Magic' Behind Every Successful Blockbuster Drug - DailyWealth - October 19th, 2019
- Synthetic presentation of noncanonical Wnt5a motif promotes mechanosensing-dependent differentiation of stem cells and regeneration - Science Advances - October 17th, 2019
- The Prognostic Importance of EVI1 Expression - Cancer Network - October 17th, 2019
- Global Longevity & Anti-Senescence Therapy Market Review 2017-2018 and Forecast to 2023 - ResearchAndMarkets.com - Business Wire - October 17th, 2019
- ROOT OF SKIN Skincare Products Sell Out in Tenth Consecutive Appearance on QVC Japan - Associated Press - October 17th, 2019
- The global T-cell therapy market size is expected to reach USD 7.51 billion, expanding at a CAGR of 15.4% by 2026 - Yahoo Finance - October 17th, 2019
- Sarah Ferguson opens up about years of plastic surgery from Botox to fillers to stem cell therapy - Evening Standard - October 17th, 2019
- Targeting CCR5 trafficking to inhibit HIV-1 infection - Science Advances - October 17th, 2019
- The Afterlife of Afterbirth - MedPage Today - October 15th, 2019
- Benefit of CD19-Targeted CAR-T Therapy in Patients With Transformed Waldenstrm Macroglobulinemia - Cancer Therapy Advisor - October 15th, 2019
- Rocket Pharmaceuticals Announces Upcoming Presentations at the European Society of Gene and Cell Therapy Annual Congress - Business Wire - October 15th, 2019
- Equine Medical Research Funding Receives USEA Board of Governors - United States Eventing Association - October 15th, 2019
- ROOT OF SKIN Skincare Products Sell Out in Tenth Consecutive Appearance on QVC Japan - PRNewswire - October 15th, 2019
- Joy as funding rises for Moscow treatment trip - Northern Times - October 15th, 2019
- Sarah Ferguson reveals highlight of my life as she celebrates 60th birthday - Express - October 15th, 2019
- Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Is Segmented On The Basis Of Product, Technology And End User 2026 - Statsflash - October 15th, 2019
- Second annual Regenerative Medicine summit proves big win for The Bahamas - EyeWitness News - October 15th, 2019
- UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon - TechCrunch - October 15th, 2019
- Ridgefield woman, her mother write book about battle with MS - The Columbian - October 15th, 2019
- How the bodys cells can prevent the need for surgery - ABC 4 - October 15th, 2019
- ReNeuron cell-based treatment hailed by leading non-profit group funding research into treatments for retinal degenerative diseases - Proactive... - October 15th, 2019
- Gay Couple Adopt HIV-Positive Child After She Was Rejected By Ten Other Families - UNILAD - October 15th, 2019
- Coming Unstuck and Reaching Beyond Ourselves - ALS News Today - October 13th, 2019
- Cody Garbrandt looking at a March start for road back to the top - MMA Mania - October 13th, 2019
- Exclusive Growth Report on Animal Stem Cell Therapy Market 2019 Increasing Demand with Leading Key Players: J-ARM,U.S. Stem Cell,Celavet Inc. - Pledge... - October 13th, 2019
- Sarah Ferguson gets candid on using Botox, laser facelifts and stem cell therapy for her feet - Fox News - October 12th, 2019
- Drexel on the Road: Stem cell study for osteoarthritis - WKRG News 5 - October 12th, 2019
- Sarah Ferguson was in pain during Eugenies wedding - and needed treatment to recover - Express - October 12th, 2019
- Jazz plays itself into cell therapy - Vantage - October 12th, 2019
- Gnaw on the Remake of David Cronenberg's 'Rabid' This December [Trailer] - Bloody Disgusting - October 12th, 2019
- Advanced Research Report on Animal Stem Cell Therapy Market 2019 Potentially Growing Significant Business Opportunities with top companies U.S. Stem... - October 12th, 2019
- Stem Cell Therapy Market 2019: Prosperous Growth, Recent Trends and Demand by Top Key Vendors like Osiris Therapeutics, MEDIPOST Co., Anterogen Co.,... - October 12th, 2019
- BEYOND LOCAL: Expert recommends 'path of cautious optimism' about the future of stem cell treatment - TimminsToday - October 10th, 2019
- Golf: Brooks Koepka healthy again after stem cell treatment but game rusty - The Straits Times - October 10th, 2019
- New Viral Vector for Sickle Cell Gene Therapy Likely to Be More Effective, NIH Study Says - Sickle Cell Anemia News - October 10th, 2019
- R3 Stem Cell Announces Addition of World Renowned Exosome Expert Dr. Ian White to Training Course - Yahoo Finance - October 10th, 2019
- Novartis completes certification of initial sites in Quebec for first approved Canadian CAR-T therapy, Kymriah (tisagenlecleucel)(i) - Canada NewsWire - October 10th, 2019
- Novo Nordisk and bluebird bio Enter 3-Year Gene Therapy Collaboration Pact - BioSpace - October 10th, 2019
- Preclinical Data Indicating Allocetra-OTS As Potential Therapy For Prevention Of Organ Failure And Mortality Associated with Severe Sepsis Selected... - October 10th, 2019
- Caroline Wyatt: The fight to reverse damage caused by MS - BBC News - October 10th, 2019
- AVROBIO Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis - Business Wire - October 10th, 2019
- We believe we can stop MS, and this is how - Metro.co.uk - October 10th, 2019
- Brooks Koepka had stem cell treatment on knee during offseason - ESPN - October 4th, 2019
- Early clinical trial for ALS sufferers shows biotech firm 'on the right track' - The Times of Israel - October 4th, 2019
- "I have talked about this treatment for so long... I finally gave in and set up the GoFundMe page. It killed me to have to do it." - Echo... - October 4th, 2019
- Global Cell Therapy Technologies Market Industry Analysis and Forecast (2018-2026) - Markets Gazette - October 4th, 2019
- Brooks Koepka Reveals He Had Stem Cell Treatment on Knee Injury in PGA Offseason - Bleacher Report - October 3rd, 2019
- Michael Schumacher health latest: What is stem cell therapy and how will it help Schumi? - Express.co.uk - October 3rd, 2019
- Exploring the Latest in CRISPR and Stem Cell Research - Technology Networks - October 3rd, 2019
- AIVITA Biomedical Announces Publication Concerning a Predictive Biomarker for Melanoma Patients Treated with the Company's Platform Immunotherapy -... - October 3rd, 2019
- Improved Gene Therapy in Sickle Cell Disease - Technology Networks - October 3rd, 2019
- Biochemistry Graduate is the Researcher's Researcher at Advanced BioCatalytics - AroundtheO - October 3rd, 2019
- Pike families to enter part of mine day before widow's cancer treatment begins - Stuff.co.nz - October 3rd, 2019
- Adcetris May Be Effective in Heavily Pre-Treated Hodgkin's Cases, Study Shows - Lymphoma News Today - October 3rd, 2019
- Warwick mum's fundraising ball to help fund 50000 treatment to fight the progression of MS - Warwick Courier - October 3rd, 2019
- Bone marrow donor registry pleas for more diversity to help save people with cancer - ABC News - October 3rd, 2019
- I hope treatment will stop Multiple Sclerosis in its tracks - Echo Live - October 3rd, 2019
- Stem Cell Therapy Market Synthesis and Opportunity Assessment 2019-2024 - Markets Gazette - October 3rd, 2019
- R3 Stem Cell Launches Master Class Series on Stem Cell Therapy and Regenerative Medicine - PRNewswire - October 1st, 2019
- ElevateBio Launches HighPassBio to Advance Novel Targeted T Cell Immunotherapies with Technology from Fred Hutchinson Cancer Research Center -... - October 1st, 2019
- Michael Schumachers surgeon denies hes performing experiments on F1 legend with stem cell treatment and sl - The Sun - October 1st, 2019
- Regenerative Stem Cell Therapy Pioneer, Celavie Biosciences, LLC, to Attend Cell & Gene Meeting on the Mesa on October 2 4 in Carlsbad,... - October 1st, 2019
- Positive Study Results of Phase IIa Clinical Trial Using Intravenous Administration of Mesenchymal Stem Cells for Ischemic Stroke Published in... - October 1st, 2019
- The Shocking Culture of Nurses and the Treatment of Patients with Sickle Cell - Nurse.org - October 1st, 2019
- CBMG: Initiating Coverage of Cellular Biomedicine Group; Multiple Cell-Based Therapies to Treat Cancer and Degenerative Diseases - Zacks Small Cap... - October 1st, 2019
- Brestoff, Theunissen recognized by NIH for innovative research - Washington University School of Medicine in St. Louis - October 1st, 2019
- Major Talent Acquisition Takes Montreal-Based Morphocell Technologies to the Next Level - BioSpace - October 1st, 2019
- Lineage Cell Therapeutics to Present New OpRegen Data at American Academy of Ophthalmology Annual Meeting on October 14, 2019 - Business Wire - October 1st, 2019
- Platelet BioGenesis Receives $56 Million Contract from the Biomedical Advanced Research and Development Authority (BARDA) to Develop Human Stem... - October 1st, 2019
- VetStem Biopharma Shares the Success Story of Cheyenne Who Was Treated with VetStem Cell Therapy by Dr. Scott Reiners - PR Web - October 1st, 2019
- Manav Rachna International Institute of Research and Studies, Faridabad and Advancells Announce Industry-Academia, Noida - Business Wire India - October 1st, 2019